Optex Systems (OPXS) Q4 2025 earnings review
Record Profits, CEO Exit, and a Backlog Warning
Optex delivered a banner FY25 with Revenue rising 22% to $41.3M and Net Income jumping 37% to $5.1M. Operational execution was stellar, particularly in the Richardson segment where throughput gains drove a 30% sales spike. However, the report contains two significant sobering notes: CEO Danny Schoening is resigning effective immediately, and the Book-to-Bill ratio has slipped below 1.0 (0.88x), meaning the company is burning backlog faster than it is replacing it. While the balance sheet is pristine (zero debt, cash up 6x), the looming US government funding delays threaten momentum in mid-FY26.
🐂 Bull Case
Gross margin expanded to 29.2% (up 120bps), and Operating Income surged 48% on 22% sales growth. The company is successfully leveraging fixed overhead across higher volumes, particularly in the periscope line.
Cash position skyrocketed from $1.0M to $6.4M year-over-year while paying off the entire $1.0M credit facility. With working capital at $21.1M, Optex is self-funding its growth and CapEx plans.
🐻 Bear Case
FY25 Revenue was $41.3M, but new orders were only $36.2M (down 0.5% YoY). The company is consuming its backlog. Without a pickup in award timing, revenue growth will mathematically stall.
Management explicitly flagged that federal funding delays (Continuing Resolution) slowed contract awards and may negatively impact revenue in Q2-Q4 of FY26.
⚖️ Verdict: ⚪
Neutral. The backward-looking financials are excellent (Grade 5), but the forward-looking indicators (Book-to-Bill < 1, CEO departure, government budget warnings) suggest the easy growth phase is pausing. The stock may struggle for direction until the order book stabilizes.
Key Themes
Optex Richardson Production Ramp
Accelerating. The Richardson segment is the engine room, growing revenue 30.8% YoY ($5.6M increase). This was driven specifically by a 56% increase in production throughput on the periscope line. This efficiency is the primary contributor to the improved absorption of fixed costs and gross margin expansion.
Book-to-Bill Ratio Deterioration
Reversing. In FY24, orders ($36.4M) exceeded revenue ($34.0M). In FY25, the dynamic flipped: Revenue ($41.3M) significantly outpaced Orders ($36.2M). The company cites delays in ARC III Abrams replenishment and BNVG Night Vision awards. This depletion of the backlog buffer is a structural risk for FY26 growth.
Executive Transition
Danny Schoening has resigned as CEO effective December 20, 2025, though he remains Chairman. President Chad George (ex-Leonardo DRS, Raytheon) assumes the CEO role. While George has strong operational pedigree, sudden CEO departures alongside record results can sometimes mask internal disagreements on future strategy or capital allocation.
Cash Conversion Engine
Operating Cash Flow was $6.9M in FY25, exceeding Net Income of $5.1M. This indicates high quality of earnings. The company generated enough cash to fund operations, pay down debt, buy $0.5M in CapEx, and still add $5.3M to the cash pile. This gives the new CEO significant optionality for M&A or dividends.
Applied Optics Center (AOC) Stability
Stable. The AOC segment grew 11.1%, driven by higher demand for military products, specifically laser filters. This offset softness in optical assemblies. While growing slower than Richardson, AOC provides the high-margin technical coating capability that serves as a competitive moat.
Macro Headwind: Congressional Gridlock
Management explicitly linked the 2025 government shutdown and the current Continuing Resolution (CR) through Jan 2026 to a slowdown in contract awards. They anticipate these funding delays may impact revenue specifically in Q2, Q3, and Q4 of FY26. This external factor is out of company control but directly threatens the top line.
Commercial Product & Tech Investment
The company incurred an $0.8M asset impairment related to the Speedtracker product line acquisition. While the company plans $2.4M in CapEx next year to develop new capabilities and rapid prototyping, the impairment suggests the commercial diversification strategy (Speedtracker) is struggling to gain traction compared to the core defense business.
Other KPIs
Accelerating. Up from 28.0% in FY24. The 120 bps improvement highlights the benefits of fixed cost absorption. As revenue scaled 21.6%, gross profit scaled 26.5%.
Accelerating. Up 40.1% YoY ($2.3M increase). EBITDA margin is now 19.4%, a very healthy level for a hardware manufacturer, driven by the operational leverage discussed in themes.
Accelerating. Up from $1.0 million in FY24. This 6x increase provides a safety net against the potential FY26 revenue volatility caused by government funding delays.
Guidance
Accelerating. Significant increase compared to the $0.5M spent in FY25. Funds are targeted for capacity expansion and new capabilities at AOC. This suggests management sees long-term demand despite the short-term order book weakness.
Management warns that funding delays (CR through Jan 2026) "may affect our revenue during the second through fourth quarters of fiscal year 2026." No specific range provided, but the tone is cautious.
Key Questions
Backlog Erosion Strategy
With the Book-to-Bill ratio dropping below 1.0 ($36.2M orders vs $41.3M revenue), at what point in FY26 does the backlog burn become critical for sustaining production rates?
CEO Transition Context
Danny Schoening is resigning immediately following a record year. Can the Board elaborate on whether this signals a shift in strategy, particularly regarding capital allocation of the $6.4M cash pile?
Commercial Strategy Viability
Given the $0.8M impairment on the Speedtracker line, is the company rethinking its diversification into commercial optical products, or is this viewed as a one-time stumble?
CapEx Ramp Justification
You plan to spend $2.4M on CapEx next year (up significantly from $0.5M) despite warning of revenue risks from government delays. What specific programs or orders underpin this aggressive investment capacity?